Pharma October 8, 2026 0 Comments

IPM volume growth at 3.4% marks 2-yr high on steady demand across therapies – Business Standard

IPM volume growth at 3.4% marks 2-yr high on steady demand across therapies Business Standard

Read the full story at source →

Add your Biographical Information. Edit your Profile now.

Why it is essential to improve cardiac rehabilitation completion rates in India

Next post

Sophie Cunningham's hat sparks transgender row: What it says and where can one get it?

0

Indian pharma supply chain: China dependence, AI & cold chain, with Anshul Agrawal, SCL Lifesciences – Logistics Update Africa

0

Pharma Sector Sets Sights on Innovation Beyond Generics – Chemical Industry Digest

0

Indigenisation of Input Material Sourcing by Top Pharma Companies – The Financial World

Post Comment Cancel reply